Keeping pace with the technological breakthroughs in the fields of biotransformation, fermentation and metabolic engineering, PharmaZell – in close collaboration with Stuttgart University's Institute of Technical Biochemistry (ITB) – has developed a new biocatalyst for the selective synthesis of a highly advanced pharmaceutical compound, expressing it in a recombinant E. coli strain.
[more...]
15.04.2008: PharmaZell opens new development center in India - Development work on active generic substances and exclusive customer developments
Having set up a development group in Chennai, pharmaceuticals manufacturer PharmaZell has now opened a second development center in India at Vizag (Visakhapatnam): PharmaZell R&D (India) Private Limited.
[more...]
02.07.2007: PharmaZell started construction of a grass root API production facility in Visakhapatnam/India
The PharmaZell group reached another milestone on its dynamic growth path with the groundbreaking ceremony Bhoomi Pooja in Visakhapatnam (A.P., India) on June 22nd, 2007.
[more...]
01.06.2007: PharmaZell GmbH, located near Munich, Germany acquired on June 1, 2007 a controlling stake in GEA Pharmaceutical A/S located in Copenhagen, Denmark from Sandoz.
GEA Pharmaceutical A/S focuses on the development of solid finished dosage forms. It offers all services related to pharmaceutical development ranging from analytics to the filing of pharmaceutical registration dossiers.
[more...]
